Morning Trend | LEPU BIO-B shows weak fluctuations in the range, what to pay attention to in this subtle market window?

LEPU BIO-B (2157.HK) shows a clear bottom weak oscillation pattern in its daily chart, with the MACD dead cross failing to effectively repair, and the green bars slowly increasing, indicating that the technical rebound is hindered. The company's stock price has repeatedly attempted to rise above the short-term moving averages without success, and the main capital shows a heavy wait-and-see sentiment, lacking short-term hot spots to activate the market. The biotechnology sector as a whole has recently performed poorly, lacking systematic thematic drivers, and the willingness of external funds to flow in is low. In terms of fundamentals, LEPU BIO focuses on the biopharmaceutical field and has strong innovation capabilities, but is constrained by regulatory policies and market pressures, with its profit model not fully established, lacking strong stimulus terms in the short term. Recently, there has been a lack of significant R&D and industrial cooperation news, and the valuation is in a repeated bottom range. Technically, attention should be paid to the lower Bollinger Band and historical support levels on the daily chart; a breach may bring new round of adjustment pressure. It is recommended that investors adopt a defensive wait-and-see approach in the short term, closely monitor the capital flow in the sector and the progress of the company's new products, and wait for a volume breakout confirmation before participating in the oversold recovery. Without effective catalysts, it is only suitable for low-position testing and swing participation, with strict control over stop-loss levels. In the medium to long term, there will only be significant upside potential on the right side if industry regulation and the company's fundamentals improve simultaneously